While eplerenone produced clear cardiorenal protective effects in our model of obesity, we acknowledge the absence of parallel improvements in systemic blood pressure and whole‐body insulin tolerance. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.